The U.S. Centers for Disease Control and Prevention (CDC) is putting $2.1 million behind a study to be conducted by Johns Hopkins researchers, using technology developed by a local startup.
The study is designed to see if financial incentives improve the likelihood that patients recovering from opioid use disorder stick to their medication plans. Emocha Mobile Health, a Baltimore health tech firm with ties to Hopkins, has developed a platform designed to increase this so-called "medication adherence"…
